Washington Trust Advisors’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $290 | Hold |
160
| – | – | ﹤0.01% | 631 |
|
|
2025
Q1 | $325 | Sell |
160
-1
| -0.6% | -$2 | ﹤0.01% | 636 |
|
|
2024
Q4 | $962 | Hold |
161
| – | – | ﹤0.01% | 639 |
|
|
2024
Q3 | $1.57K | Hold |
161
| – | – | ﹤0.01% | 645 |
|
|
2024
Q2 | $3.29K | Hold |
161
| – | – | ﹤0.01% | 605 |
|
|
2024
Q1 | $7.25K | Hold |
161
| – | – | ﹤0.01% | 524 |
|
|
2023
Q4 | $7.59K | Buy |
161
+83
| +106% | +$3.91K | ﹤0.01% | 519 |
|
|
2023
Q3 | $3.16K | Hold |
78
| – | – | ﹤0.01% | 604 |
|
|
2023
Q2 | $8.33K | Hold |
78
| – | – | ﹤0.01% | 485 |
|
|
2023
Q1 | $23.3K | Hold |
78
| – | – | ﹤0.01% | 398 |
|
|
2022
Q4 | $26.9K | Hold |
78
| – | – | ﹤0.01% | 383 |
|
|
2022
Q3 | $15K | Hold |
78
| – | – | ﹤0.01% | 546 |
|
|
2022
Q2 | $16K | Buy |
78
+62
| +388% | +$12.7K | ﹤0.01% | 569 |
|
|
2022
Q1 | $5K | Hold |
16
| – | – | ﹤0.01% | 812 |
|
|
2021
Q4 | $5K | Buy |
+16
| New | +$5K | ﹤0.01% | 842 |
|